Characterization of the β-tubulin gene family in Ascaris lumbricoides and Ascaris suum and its implication for the molecular detection of benzimidazole resistance.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
09 2021
Historique:
received: 28 04 2021
accepted: 29 08 2021
revised: 07 10 2021
pubmed: 28 9 2021
medline: 15 12 2021
entrez: 27 9 2021
Statut: epublish

Résumé

The treatment coverage of control programs providing benzimidazole (BZ) drugs to eliminate the morbidity caused by soil-transmitted helminths (STHs) is unprecedently high. This high drug pressure may result in the development of BZ resistance in STHs and so there is an urgent need for surveillance systems detecting molecular markers associated with BZ resistance. A critical prerequisite to develop such systems is an understanding of the gene family encoding β-tubulin proteins, the principal targets of BZ drugs. First, the β-tubulin gene families of Ascaris lumbricoides and Ascaris suum were characterized through the analysis of published genomes. Second, RNA-seq and RT-PCR analyses on cDNA were applied to determine the transcription profiles of the different gene family members. The results revealed that Ascaris species have at least seven different β-tubulin genes of which two are highly expressed during the entire lifecycle. Third, deep amplicon sequencing was performed on these two genes in more than 200 adult A. lumbricoides (Ethiopia and Tanzania) and A. suum (Belgium) worms, to investigate the intra- and inter-species genetic diversity and the presence of single nucleotide polymorphisms (SNPs) that are associated with BZ resistance in other helminth species; F167Y (TTC>TAC or TTT>TAT), E198A (GAA>GCA or GAG>GCG), E198L (GAA>TTA) and F200Y (TTC>TAC or TTT>TAT). These particular SNPs were absent in the two investigated genes in all three Ascaris populations. This study demonstrated the presence of at least seven β-tubulin genes in Ascaris worms. A new nomenclature was proposed and prioritization of genes for future BZ resistance research was discussed. This is the first comprehensive description of the β-tubulin gene family in Ascaris and provides a framework to investigate the prevalence and potential role of β-tubulin sequence polymorphisms in BZ resistance in a more systematic manner than previously possible.

Sections du résumé

BACKGROUND
The treatment coverage of control programs providing benzimidazole (BZ) drugs to eliminate the morbidity caused by soil-transmitted helminths (STHs) is unprecedently high. This high drug pressure may result in the development of BZ resistance in STHs and so there is an urgent need for surveillance systems detecting molecular markers associated with BZ resistance. A critical prerequisite to develop such systems is an understanding of the gene family encoding β-tubulin proteins, the principal targets of BZ drugs.
METHODOLOGY AND PRINCIPAL FINDINGS
First, the β-tubulin gene families of Ascaris lumbricoides and Ascaris suum were characterized through the analysis of published genomes. Second, RNA-seq and RT-PCR analyses on cDNA were applied to determine the transcription profiles of the different gene family members. The results revealed that Ascaris species have at least seven different β-tubulin genes of which two are highly expressed during the entire lifecycle. Third, deep amplicon sequencing was performed on these two genes in more than 200 adult A. lumbricoides (Ethiopia and Tanzania) and A. suum (Belgium) worms, to investigate the intra- and inter-species genetic diversity and the presence of single nucleotide polymorphisms (SNPs) that are associated with BZ resistance in other helminth species; F167Y (TTC>TAC or TTT>TAT), E198A (GAA>GCA or GAG>GCG), E198L (GAA>TTA) and F200Y (TTC>TAC or TTT>TAT). These particular SNPs were absent in the two investigated genes in all three Ascaris populations.
SIGNIFICANCE
This study demonstrated the presence of at least seven β-tubulin genes in Ascaris worms. A new nomenclature was proposed and prioritization of genes for future BZ resistance research was discussed. This is the first comprehensive description of the β-tubulin gene family in Ascaris and provides a framework to investigate the prevalence and potential role of β-tubulin sequence polymorphisms in BZ resistance in a more systematic manner than previously possible.

Identifiants

pubmed: 34570778
doi: 10.1371/journal.pntd.0009777
pii: PNTD-D-21-00603
pmc: PMC8496844
doi:

Substances chimiques

Anthelmintics 0
Benzimidazoles 0
Tubulin 0
benzimidazole E24GX49LD8

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0009777

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Parasitol Today. 1990 Apr;6(4):112-5
pubmed: 15463312
Int J Parasitol. 2012 May 1;42(5):469-79
pubmed: 22787588
Vet Parasitol. 2005 May 15;129(3-4):291-8
pubmed: 15845285
Parasitology. 2007;134(Pt 8):1077-86
pubmed: 17608967
Nat Genet. 2014 Mar;46(3):261-269
pubmed: 24441737
Parasite Immunol. 2011 Apr;33(4):250-4
pubmed: 21204852
Biochem Biophys Res Commun. 1993 Mar 15;191(2):413-9
pubmed: 8096381
Rev Soc Bras Med Trop. 2020 Mar 16;53:e20190155
pubmed: 32187331
Genome Res. 2011 Sep;21(9):1462-77
pubmed: 21685128
Genes Dev. 1989 Jun;3(6):870-81
pubmed: 2744465
Int J Parasitol Drugs Drug Resist. 2012 Mar 03;2:92-7
pubmed: 24533269
Elife. 2020 Nov 06;9:
pubmed: 33155980
Mol Biochem Parasitol. 2002 Apr 9;120(2):297-300
pubmed: 11897135
PLoS Negl Trop Dis. 2015 Feb 06;9(2):e0003494
pubmed: 25658086
PLoS One. 2013 Aug 12;8(8):e70212
pubmed: 23950913
PLoS Negl Trop Dis. 2019 Aug 1;13(8):e0007471
pubmed: 31369562
J Parasitol. 2004 Aug;90(4):868-70
pubmed: 15357086
Proc Natl Acad Sci U S A. 1973 Dec;70(12):3321-3
pubmed: 4519626
Mol Biochem Parasitol. 1994 Feb;63(2):299-303
pubmed: 7911975
Vet Parasitol. 2012 May 25;186(3-4):344-9
pubmed: 22192770
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
Genetics. 2010 Jul;185(3):883-96
pubmed: 20421600
Parasitology. 2003 Dec;127(Pt 6):579-88
pubmed: 14700194
Nat Biotechnol. 2016 May;34(5):525-7
pubmed: 27043002
Bioinformatics. 2014 May 1;30(9):1312-3
pubmed: 24451623
Mol Biochem Parasitol. 2009 Nov;168(1):120-2
pubmed: 19616042
PLoS One. 2019 Oct 17;14(10):e0224108
pubmed: 31622428
Vet Parasitol. 2007 Mar 31;144(3-4):313-20
pubmed: 17101226
Nucleic Acids Res. 2016 Jan 4;44(D1):D774-80
pubmed: 26578572
Bioinformatics. 2001 Aug;17(8):754-5
pubmed: 11524383
Vet Parasitol. 2009 Apr 6;161(1-2):60-8
pubmed: 19155135
PLoS One. 2015 Dec 02;10(12):e0143559
pubmed: 26630572
PLoS Negl Trop Dis. 2018 Mar 30;12(3):e0006368
pubmed: 29601575
Nucleic Acids Res. 2019 Jul 2;47(W1):W256-W259
pubmed: 30931475
Int J Parasitol Drugs Drug Resist. 2011 Oct 14;1(1):14-27
pubmed: 24533260
Am J Trop Med Hyg. 2013 Jun;88(6):1052-61
pubmed: 23458960
Dev Cell. 2012 Nov 13;23(5):1072-80
pubmed: 23123092
Parasitology. 2003 Jul;127(Pt 1):53-9
pubmed: 12885188
Int J Parasitol Drugs Drug Resist. 2017 Dec;7(3):262-271
pubmed: 28697451
Mol Biochem Parasitol. 2013 Jul;190(1):38-43
pubmed: 23685342
J Cell Biol. 1989 Dec;109(6 Pt 1):2993-3003
pubmed: 2592410
Nat Genet. 2019 Jan;51(1):163-174
pubmed: 30397333
Parasit Vectors. 2019 Dec 9;12(1):576
pubmed: 31818311
PLoS Negl Trop Dis. 2009;3(3):e397
pubmed: 19308251
Nucleic Acids Res. 2021 Jan 8;49(D1):D412-D419
pubmed: 33125078
PLoS Negl Trop Dis. 2018 Nov 2;12(11):e0006912
pubmed: 30388108
PLoS Pathog. 2018 Oct 29;14(10):e1007226
pubmed: 30372484
Nature. 2011 Oct 26;479(7374):529-33
pubmed: 22031327
J Cell Sci. 1994 Aug;107 ( Pt 8):2165-75
pubmed: 7983175
Wkly Epidemiol Rec. 2012 Jun 8;87(23):225-32
pubmed: 24340403
Science. 1998 Dec 11;282(5396):2012-8
pubmed: 9851916
Int J Parasitol. 2019 Jan;49(1):13-26
pubmed: 30471287
Nucleic Acids Res. 1997 Sep 1;25(17):3389-402
pubmed: 9254694
PLoS Negl Trop Dis. 2018 Sep 17;12(9):e0006766
pubmed: 30222749
Trop Med Infect Dis. 2019 Apr 27;4(2):
pubmed: 31035610
Int J Parasitol Drugs Drug Resist. 2020 Dec;14:28-36
pubmed: 32858477
Mol Ecol Resour. 2015 Sep;15(5):1172-8
pubmed: 25644761
Nat Genet. 2014 Jul;46(7):693-700
pubmed: 24929830
PLoS Negl Trop Dis. 2017 Jan 12;11(1):e0005205
pubmed: 28081124
Nature. 1998 Mar 5;392(6671):71-5
pubmed: 9510248
Vet Parasitol. 1999 Jan 14;80(3):231-7
pubmed: 9950346
PLoS Negl Trop Dis. 2013 Oct 03;7(10):e2467
pubmed: 24098821
Mol Biochem Parasitol. 2017 Jul;215:2-10
pubmed: 27899279
Int J Parasitol. 2013 May;43(6):465-75
pubmed: 23416426
Int J Parasitol. 2002 Jun 15;32(7):921-8
pubmed: 12062563
PLoS Negl Trop Dis. 2020 Feb 6;14(2):e0007931
pubmed: 32027646
Nucleic Acids Res. 2004 Mar 19;32(5):1792-7
pubmed: 15034147
Commun Biol. 2020 Nov 9;3(1):656
pubmed: 33168940
PLoS Negl Trop Dis. 2013 May 30;7(5):e2247
pubmed: 23738029
Pharmacogenet Genomics. 2008 Feb;18(2):129-40
pubmed: 18192899

Auteurs

Sara Roose (S)

Department of Virology, Parasitology and Immunology, Ghent University, Merelbeke, Belgium.

Russell W Avramenko (RW)

Department of Comparative Biology and Experimental Medicine, Faculty of Veterinary Medicine, Host-Parasite Interactions (HPI) Research Training Network, University of Calgary, Calgary, Alberta, Canada.

Stephen M J Pollo (SMJ)

Department of Ecosystem and Public Health, Faculty of Veterinary Medicine, Host-Parasite Interactions (HPI) Research Training Network, University of Calgary, Calgary, Alberta, Canada.

James D Wasmuth (JD)

Department of Ecosystem and Public Health, Faculty of Veterinary Medicine, Host-Parasite Interactions (HPI) Research Training Network, University of Calgary, Calgary, Alberta, Canada.

Shaali Ame (S)

Public Health Laboratory-Ivo de Carneri, Chake Chake, United Republic of Tanzania.

Mio Ayana (M)

Department of Virology, Parasitology and Immunology, Ghent University, Merelbeke, Belgium.
Institute of Health, Faculty of Health Science, School of Medical Laboratory Science, Jimma University, Jimma, Ethiopia.

Martha Betson (M)

Department of Veterinary Epidemiology and Public Health, University of Surrey, Guildford, Surrey, United Kingdom.

Piet Cools (P)

Department of Virology, Parasitology and Immunology, Ghent University, Merelbeke, Belgium.

Daniel Dana (D)

Department of Virology, Parasitology and Immunology, Ghent University, Merelbeke, Belgium.
Institute of Health, Faculty of Health Science, School of Medical Laboratory Science, Jimma University, Jimma, Ethiopia.

Ben P Jones (BP)

Department of Veterinary Epidemiology and Public Health, University of Surrey, Guildford, Surrey, United Kingdom.

Zeleke Mekonnen (Z)

Institute of Health, Faculty of Health Science, School of Medical Laboratory Science, Jimma University, Jimma, Ethiopia.

Arianna Morosetti (A)

Department of Comparative Biology and Experimental Medicine, Faculty of Veterinary Medicine, Host-Parasite Interactions (HPI) Research Training Network, University of Calgary, Calgary, Alberta, Canada.

Abhinaya Venkatesan (A)

Department of Comparative Biology and Experimental Medicine, Faculty of Veterinary Medicine, Host-Parasite Interactions (HPI) Research Training Network, University of Calgary, Calgary, Alberta, Canada.

Johnny Vlaminck (J)

Department of Virology, Parasitology and Immunology, Ghent University, Merelbeke, Belgium.

Matthew L Workentine (ML)

Department of Ecosystem and Public Health, Faculty of Veterinary Medicine, Host-Parasite Interactions (HPI) Research Training Network, University of Calgary, Calgary, Alberta, Canada.

Bruno Levecke (B)

Department of Virology, Parasitology and Immunology, Ghent University, Merelbeke, Belgium.

John S Gilleard (JS)

Department of Comparative Biology and Experimental Medicine, Faculty of Veterinary Medicine, Host-Parasite Interactions (HPI) Research Training Network, University of Calgary, Calgary, Alberta, Canada.

Peter Geldhof (P)

Department of Virology, Parasitology and Immunology, Ghent University, Merelbeke, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH